Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000598
UniProt IDO14647
Primary gene name(s)CHD2
Synonym gene name(s)unknown
Protein nameChromodomain-helicase-DNA-binding protein 2
Protein functionDNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression, By similarity. {ECO:0000250}.
Subcellular locationNucleus {ECO:0000250}. Note=Binds to myogenic gene promoters. {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: O14647
Gene Ontology
(Biological Process)
Complete annatation
cellular response to DNA damage stimulus [GO:0006974];
covalent chromatin modification [GO:0016569];
hematopoietic stem cell differentiation [GO:0060218];
muscle organ development [GO:0007517];
regulation of transcription from RNA polymerase II promoter [GO:0006357];
transcription, DNA-templated [GO:0006351]
Gene Ontology
(Molecular Function)
Complete annatation
ATP binding [GO:0005524];
ATP-dependent DNA helicase activity [GO:0004003];
core promoter sequence-specific DNA binding [GO:0001046];
DNA binding [GO:0003677];
histone binding [GO:0042393];
poly(A RNA binding [GO:0044822]
Gene Ontology
(Cellular Component)
Complete annatation
extracellular exosome [GO:0070062];
intracellular membrane-bounded organelle [GO:0043231];
nucleolus [GO:0005730];
nucleoplasm [GO:0005654];
nucleus [GO:0005634]
Protein-protein interaction107531
Phylogenetic treeO14647
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-1.055658767581480.001395891664280.00486560572711105
AZA vs. DISU0.17906115656030.4780323453013560.930321227911852
AZA vs. IL7-0.1267702490067790.5082709881245550.999311006273513
AZA vs. SAHA-0.06768851729723290.7809837461867330.941728580915033
DISU vs. CD31.22149448995130.0008748042405660740.00369378126674874
DISU vs. IL7-0.3148457213621040.2108161087448660.590903989469522
DISU vs. SAHA-0.2453091609280490.3996144177037430.760071021924645
DMSO vs. AZA-0.00161552977184950.992271225194581
DMSO vs. CD31.043558655213510.001214766654119460.00405955182881758
DMSO vs. DISU-0.182231504159250.4541891100755210.890202310783654
DMSO vs. IL7-0.1180985822378660.5098450487071810.88780433692056
DMSO vs. SAHA-0.07328691702797530.755372966769550.92861477650687
HIV vs. Mock in Activation0.009758804921702520.9875059007072650.999983755607037
HIV vs. Mock in Latency0.03435373411821610.834288231120810.999834320637052
IL7 vs. CD30.9365823267725860.003776331869552730.0132558570726056
SAHA vs. CD30.9630671983556530.006825762241189470.0185809676616195
SAHA vs. IL70.05504823955662330.8207612676356730.922763858405066
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander -0.774 5.73E-07 1.12E-05
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.0599258 0.843041
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.985 1.023 0.971 1.04 0.921
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found